Skip to content

FP7H2020

Cancer Research UK Lbg

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
80
As coordinator
36
EU contribution (CORDIS)
EUR 16,198,905
Active
2008 to 2017

Projects

80 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
CD8DC FUNCTIONSDNRG-1 as a marker to develop better models for characterising human and mouse dendritic subsets and for analysing their functional role in vivoFP72009CoordinatorEUR 180,784
FUTUGEMETFunctional tumour genomics using metabolomic profilingFP72009CoordinatorEUR 180,784
BOLDBiology of Liver and Pancreatic Development and DiseaseFP72009ParticipantNot stated
SMAD1/5 AND CANCERA novel mode of TGF-beta signalling through Smad1/Smad5 phosphorylation: mechanism and functional role in cancerFP72009CoordinatorEUR 171,868
PBC-BSIn vivo study of primary B cell responsesFP72009CoordinatorEUR 169,391
SNPS AND TF BINDINGGlobally connecting single nucleotide variations to transcriptional regulation in vivoFP72009CoordinatorEUR 75,000
OPTISTEMOptimization of stem cell therapy for clinical trials of degenerative skin and muscle diseasesFP72009ParticipantEUR 250,001
EPOCEuropean Paediatric Oncology Off-Patent Medicines ConsortiumFP72009ParticipantEUR 75,750
ER_PARTNERSChromatin Mediators of Estrogen Receptor BiologyFP72009ParticipantEUR 768,797
TGF-BETA AND CANCERRegulating TGF-beta signalling at the transcriptional level and in cancerFP72008CoordinatorEUR 233,785
CHROMATIN IN SKINDeciphering the role of chromatin in epidermal stem cell biologyFP72008CoordinatorEUR 177,173
CHROMOSOME STABILITYMolecular mechanism of separase dependent PP2ACdc55 downregulationFP72008CoordinatorEUR 169,391
BCL6-C-JUN-CAXcooperation between BCL6 and c-Jun in lymphoma development and progressionFP72008CoordinatorEUR 178,307
TUMICAn integrated concept of tumor metastasis: implications for therapyFP72008ParticipantEUR 170
BRAINCAVNONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAINFP72008ParticipantEUR 39,750
GENINCAGenomic instability and genomic alterations in pre-cancerous lesions and/or cancerFP72008ParticipantNot stated
SRF COFACTORSCell Biology of SRF cofactorsFP72008CoordinatorEUR 177,740
AAMDDRDNA damage response and genome stability: The role of ATM, ATR and the Mre11 complexFP72008CoordinatorEUR 1,000,000
CANCERPATHWAYSDevelopmental Molecular Pathways in Drosophila as a Model for Human CancerFP72008ParticipantEUR 259,400
CONSERVREGCIRCUITRYConservation and Divergence of Tissue-Specific Transcriptional RegulationFP72008ParticipantEUR 860,329

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.